GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (HAM:AAQ1) » Definitions » EPS (Diluted)

aap Implantate AG (HAM:AAQ1) EPS (Diluted) : €-0.29 (TTM As of Jun. 2023)


View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG EPS (Diluted)?

aap Implantate AG's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was €-0.22. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.29.

aap Implantate AG's EPS (Basic) for the six months ended in Jun. 2023 was €-0.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.29.

aap Implantate AG's EPS without NRI for the six months ended in Jun. 2023 was €-0.22. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.27.

During the past 3 years, the average EPS without NRIGrowth Rate was 43.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 33.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, aap Implantate AG's highest 3-Year average EPS without NRI Growth Rate was 43.20% per year. The lowest was -60.90% per year. And the median was 3.25% per year.


aap Implantate AG EPS (Diluted) Historical Data

The historical data trend for aap Implantate AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG EPS (Diluted) Chart

aap Implantate AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.49 -6.06 -2.57 -0.55 -0.45

aap Implantate AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 -0.17 -0.38 -0.07 -0.22

Competitive Comparison of aap Implantate AG's EPS (Diluted)

For the Medical Devices subindustry, aap Implantate AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's PE Ratio falls into.



aap Implantate AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

aap Implantate AG's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.683-0)/5.956
=-0.45

aap Implantate AG's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.993-0)/8.966
=-0.22

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


aap Implantate AG  (HAM:AAQ1) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


aap Implantate AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


aap Implantate AG (HAM:AAQ1) Business Description

Traded in Other Exchanges
Address
Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (HAM:AAQ1) Headlines

No Headlines